Uni Super Management Pty LTD Gilead Sciences, Inc. Transaction History
Uni Super Management Pty LTD
- $15.9 Billion
- Q3 2025
A detailed history of Uni Super Management Pty LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Uni Super Management Pty LTD holds 561,992 shares of GILD stock, worth $69.7 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
561,992
Previous 546,513
2.83%
Holding current value
$69.7 Million
Previous $60.6 Million
2.95%
% of portfolio
0.39%
Previous 0.42%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
2,369Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...